Quick answer
The ANA test screens for antinuclear antibodies linked to autoimmune disease. A positive result at 1:40-1:80 is common in healthy people and rarely meaningful alone; 1:160 and above is clinically significant and usually leads to an ENA panel. ANA is positive in over 95% of lupus patients, but most ANA-positive people do not have lupus.
How to Interpret a Positive ANA
| ANA Titre | Clinical Significance |
|---|---|
| 1:40 | Very common in healthy people: low significance alone |
| 1:80 | Borderline: consider clinical context |
| 1:160 | Clinically significant: warrants further investigation with ENA panel |
| ≥1:320 | Strongly positive: high probability of autoimmune disease |
- ANA is a screening test, not a diagnosis; a positive result only gains meaning in clinical context.
- A positive ANA is common in healthy people (roughly 5-15% depending on the cut-off), and a low-titre positive on its own has little significance.
- The titre changes the meaning: results at or above 1:160 are more clinically significant and usually lead to an ENA panel.
- The staining pattern (homogeneous, speckled, nucleolar) points toward different diseases.
- ANA is positive in over 95% of lupus (SLE) patients, but the great majority of ANA-positive people do not have lupus.
- A positive result at 1:160 or above is usually followed by specific antibody tests: anti-dsDNA, anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl-70 and others.
ANA Pattern and Associated Diseases
| ANA Pattern | Associated Antibody | Condition |
|---|---|---|
| Homogeneous (diffuse) | Anti-dsDNA, anti-histone | SLE, drug-induced lupus |
| Speckled | Anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl70 | SLE, Sjögren's, scleroderma, MCTD |
| Nucleolar | Anti-Scl70, anti-PM-Scl | Systemic sclerosis |
| Centromere | Anti-centromere | Limited scleroderma (CREST) |
ENA Panel Follows Positive ANA
If ANA is positive at ≥1:160, an extractable nuclear antigen (ENA) panel is ordered: anti-dsDNA, anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl-70, anti-Jo-1, anti-centromere. These more specific antibodies guide diagnosis.
ANA titres at a glance: the compiled numbers
ANA is reported as a titre — how far your blood can be diluted before the signal disappears. Higher dilutions mean more antibody, but the numbers need careful reading:
| Titre | What it can mean* | Context that matters |
|---|---|---|
| 1:40 | Low — seen in a sizable minority of healthy people | Often not clinically significant on its own; doctors weigh symptoms heavily here |
| 1:80 | Borderline — common in healthy people, especially with age | The grey zone: meaningful mainly if symptoms or other markers point the same way |
| 1:160 | Moderate — less common without an autoimmune cause | Usually prompts a closer look and often follow-up antibody testing |
| 1:320 and above | High — more often linked to autoimmune disease | Still not a diagnosis by itself; the clinical picture and specific antibodies decide |
| Typical cost | &rupee;800–&rupee;1,500 by immunofluorescence | ELISA-based ANA screens may cost less; prices vary by city and lab |
*Interpretation is always hedged: titres are read alongside symptoms, examination and follow-up antibody tests — never alone. Prices are approximate bands, not quotes.
ANA myths vs facts
Few tests generate more anxiety per positive result than ANA. Here is what the evidence actually says:
MYTH A positive ANA means lupus.
Fact: It means antinuclear antibodies were found — which happens in lupus, but also in Sjögren's, scleroderma, autoimmune thyroid disease, chronic infections, and in healthy people, especially as they age. ANA is a door to investigation, not a diagnosis.
MYTH A higher titre means worse disease.
Fact: The titre does not track disease severity or activity. Someone with 1:1280 can be perfectly well, and someone with 1:80 can have active disease — doctors follow symptoms and organ findings, not the dilution.
MYTH A negative ANA rules out autoimmune disease.
Fact: Mostly reassuring, but not absolute. Some conditions — including certain vasculitides and seronegative arthritis — routinely show a negative ANA. Persistent symptoms deserve a rheumatologist's eyes regardless of the result.
MYTH The staining pattern names the disease.
Fact: Patterns (homogeneous, speckled, nucleolar and others) suggest directions for follow-up antibody testing, but the same pattern appears across different diseases. The pattern guides; it never concludes.
What matters most with your ANA result
- Symptoms outweigh the titre. Joint pains, rashes, mouth ulcers, Raynaud's, unexplained fevers — the clinical story decides whether a positive ANA matters, not the dilution.
- Low titres are common and often meaningless. At 1:40 or 1:80 without symptoms, most doctors simply note it; chasing it with repeated testing rarely helps.
- Follow-up antibodies do the refining. Anti-dsDNA, anti-Sm, anti-Ro and others narrow down what a positive ANA might mean — ask your doctor which, if any, are relevant for you.
- Trends are not for monitoring. Unlike CRP, the ANA titre is not used to track disease activity — repeating it to “see if it's better” is not useful. Discuss the full picture with your rheumatologist.
Frequently Asked Questions
How much does the ANA test cost in India?
What is the full form of ANA?
Does a positive ANA mean I have lupus?
What is anti-dsDNA?
Can medications cause a positive ANA?
What conditions cause a positive ANA besides lupus?
My ANA is 1:40 positive but I have no symptoms. What should I do?
Can a positive ANA turn negative again?
Can infections cause a temporary positive ANA?
Should my family members be tested if my ANA is positive?
Pharmacist's practical notes
A positive ANA lands like a diagnosis but behaves like a screening flag. The most useful thing you can do with one is also the simplest: write down your symptoms — when they started, what triggers them, what eases them — and bring that list to the rheumatologist. The history refines a positive ANA more than any repeat titre.
A few common medicines can induce a positive ANA (the drug-induced lupus list is a classic pharmacy topic), so bring your full medication list to the discussion. And resist the urge to retest the titre for reassurance: it is not a monitoring marker, and a changed number rarely changes management.
In India
Indian labs report ANA as a titre (1:40, 1:80, 1:160 and so on), often with the staining pattern. The test typically costs &rupee;800–&rupee;1,500 by immunofluorescence, though prices vary by city and lab.
Where possible, choose a NABL-accredited lab. Methods differ between labs, so the pattern and titre on your own report are what count.
References
Sources cited on this page. PubMed links open the original abstract.
- Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124(1):71–81. PMID 10629135 · doi:10.5858/2000-124-0071-GFCUOT
- O'Sullivan M, McLean-Tooke A, Loh RKS. Antinuclear antibody test. Aust Fam Physician. 2013;42(10):718–721. PMID 24130974
- Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400–1412. PMID 31385462 · doi:10.1002/art.40930
Related reading
- Guide to Autoimmune Blood TestsWhat blood tests diagnose autoimmune diseases? Learn about ANA…
- Lupus (SLE): Diagnosis & Treatment GuideComplete guide to systemic lupus erythematosus: symptoms, diagnostic…
- Rheumatoid Factor (RF) Blood TestWhat does a positive rheumatoid factor (RF) blood test mean? Normal…
- Anti-CCP & Rheumatoid Factor: Rheumatoid Arthritis TestsAnti-CCP and rheumatoid factor are the key blood tests for diagnosing…
- Widal TestWhat does a positive Widal test mean? Understand Widal test titres…
- Multiple Sclerosis (MS)What blood tests are done for multiple sclerosis? Learn how MS is…
A positive ANA is common in healthy people
This is the single most important thing to understand about the test. Depending on the cut-off used, roughly 10 to 15 per cent of entirely healthy people have a positive ANA at 1:80, and the proportion rises with age and is higher in women. A positive result in someone without symptoms therefore has a low probability of indicating disease.2 This is why the test performs badly as a screen and why guidelines discourage ordering it in the absence of clinical features suggesting connective tissue disease.
The corollary matters too: because so many well people test positive, an unexplained positive ANA frequently causes considerable anxiety and leads to further testing that finds nothing. Where a result has already been obtained without a clear indication, the sensible interpretation is to weigh it against the clinical picture rather than to pursue it in isolation.
Titre changes what the result means
- 1:40 to 1:80 is weakly positive and frequently seen in healthy individuals.
- 1:160 is moderately positive and warrants correlation with symptoms.
- 1:320 and above is more likely to be clinically significant, particularly with a defined pattern.
Titres are reported as doubling dilutions, so each step represents a twofold change. A shift from 1:160 to 1:320 is one dilution and may reflect assay variation rather than disease activity, which is why ANA titres are not used to monitor established disease.
What follows a meaningful positive
Where the clinical picture supports it, the next step is specific antibody testing rather than repeating the ANA: anti-dsDNA and anti-Sm for lupus, anti-Ro and anti-La for Sjögren's, anti-centromere and anti-Scl-70 for systemic sclerosis, anti-Jo-1 for myositis. Complement levels, urinalysis for protein and blood, and a full blood count are usually checked at the same time, since organ involvement matters more than serology. A negative ANA makes lupus unlikely but does not exclude every connective tissue disease, and some conditions are ANA-negative by nature.